Arterial and venous thrombosis in patients with monoclonal gammopathy of undetermined significance: Incidence and risk factors in a cohort of 1491 patients

British Journal of Haematology

Volumn 160, Issue 5, 2013, Pages 673-679

  Za, Tommaso ^a   De Stefano, Valerio ^a   Rossi, Elena ^a   Petrucci, Maria Teresa ^b   Andriani, Alessandro ^c   Annino, Luciana ^d   Cimino, Giuseppe ^b   Caravita, Tommaso ^e   Pisani, Francesco ^f   Ciminello, Angela ^a   Torelli, Fabio ^b   Villivà, Nicoletta ^c   Bongarzoni, Velia ^d   Rago, Angela ^b   Betti, Silvia ^a   Levi, Anna ^b   Felici, Stefano ^c   Gentilini, Fabiana ^b   Calabrese, Elisabetta ^b   Leone, Giuseppe ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c NUOVO REGINA MARGHERITA HOSPITAL   (Italy)

^d SAN GIOVANNI ADDOLORATA HOSPITAL   (Italy)

^e UNIVERSITY OF ROME TOR VERGATA   (Italy)

^f REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Arterial thrombosis; Monoclonal gammopathy of undetermined significance; Venous thrombosis

Indexed keywords

M PROTEIN;

ADULT; AGED; ARTERY THROMBOSIS; ARTICLE; CARDIOVASCULAR RISK; COHORT ANALYSIS; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; FOLLOW UP; HEMATOLOGIC MALIGNANCY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MONOCLONAL IMMUNOGLOBULINEMIA; MULTIPLE MYELOMA; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; RISK ASSESSMENT; VEIN THROMBOSIS;

ADULT; AGED; AGED, 80 AND OVER; ARTERIAL OCCLUSIVE DISEASES; ATRIAL FIBRILLATION; DIABETES COMPLICATIONS; DISEASE PROGRESSION; DYSLIPIDEMIAS; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; INCIDENCE; ITALY; MALE; MIDDLE AGED; MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE; MULTIPLE MYELOMA; MYELOMA PROTEINS; MYOCARDIAL ISCHEMIA; NEOPLASMS; RETROSPECTIVE STUDIES; RISK FACTORS; SMOKING; STROKE; THROMBOPHILIA; THROMBOSIS; VENOUS THROMBOSIS; YOUNG ADULT;

EID: 84873998358     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.12168     Document Type: Article

References (21)

1. Bennett, C.L., Angelotta, C., Yarnold, P.R., Evens, A.M., Zonder, J.A., Raisch, D.W. & Richardson, P. (2006) Thalidomide- and lenalidomide-associated thromboembolism among patients with cancer. JAMA, 296, 2558-2560.
2. Bida, J.P., Kyle, R.A., Therneau, T.M., Melton, L.J. 3rd, Plevak, M.F., Larson, D.R., Dispenzieri, A., Katzmann, J.A. & Rajkumar, S.V. (2009) Disease association with monoclonal gammopathy of undetermined significance: a population-based study of 17, 398 patients. Mayo Clinic Proceedings, 84, 685-693.
3. Blom, J.W., Doggen, C.J., Osanto, S. & Rosendaal, F.R. (2005) Malignancies, prothrombotic mutations, and the risk of venous thrombosis. JAMA, 293, 715-722.
4. Cohen, A.L. & Sarid, R. (2010) The relationship between monoclonal gammopathy of undetermined significance and venous thromboembolic disease. Thrombosis Research, 125, 216-219.
5. Cronin-Fenton, D.P., Søndergaard, F., Pedersen, L.A., Fryzek, J.P., Cetin, K., Acquavella, J., Baron, J.A. & Sørensen, H.T. (2010) Hospitalisation for venous thromboembolism in cancer patients and the general population: a population-based cohort study in Denmark, 1997-2006. British Journal of Cancer, 103, 947-953.
6. De Stefano, V., Za, T., Rossi, E., Vannucchi, A.M., Ruggeri, M., Elli, E., Micò, C., Tieghi, A., Cacciola, R.R., Santoro, C., Gerli, G., Vianelli, N., Guglielmelli, P., Pieri, L., Scognamiglio, F., Rodeghiero, F., Pogliani, E.M., Finazzi, G., Gugliotta, L., Marchioli, R., Leone, G., Barbui, T.; GIMEMA CMD-Working Party. (2008) Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments. Haematologica, 93, 372-380.
7. Driver, J.A., Djoussé, L., Logroscino, G., Gaziano, J.M. & Kurth, T. (2008) Incidence of cardiovascular disease and cancer in advanced age: prospective cohort study. British Medical Journal, 337, a2467.
8. Gregersen, H., Nørgaard, M., Severinsen, M.T., Engebjerg, M.C., Jensen, P. & Sørensen, H.T. (2011) Monoclonal gammopathy of undetermined significance and risk of venous thromboembolism. European Journal of Haematology, 86, 129-134.
9. Hansson, P.O., Welin, L., Tibblin, G. & Eriksson, H. (1997) Deep vein thrombosis and pulmonary embolism in the general population. 'The Study Of Men Born in 1913'. Archives of Internal Medicine, 157, 1665-1670.
10. Heit, J.A., Silverstein, M.D., Mohr, D.N., Petterson, T.M., O'Fallon, W.M. & Melton, L.J. (2000) Risk factors for deep vein thrombosis and pulmonary embolism. A population-based case-control study. Archives of Internal Medicine, 160, 809-815.
11. Heit, J.A., O'Fallon, W.M., Petterson, T.M., Lohse, C.M., Silverstein, M.D., Mohr, D.N. & Melton, L.J. (2002) Relative impact of risk factors for deep vein thrombosis and pulmonary embolism. A population-based case-control study. Archives of Internal Medicine, 162, 1245-1248.
12. Huerta, C., Johansson, S., Wallander, M.A. & García Rodríguez, L.A. (2007) Risk factors and short-term mortality of venous thromboembolism diagnosed in the primary care setting in the United Kingdom. Archives of Internal Medicine, 167, 935-943.
13. International Myeloma Working Group (2003) Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group. British Journal of Haematology, 121, 749-757.
14. Kristinsson, S.Y., Fears, T.R., Gridley, G., Turesson, I., Mellqvist, U.H., Björkholm, M. & Landgren, O. (2008) Deep vein thrombosis after monoclonal gammopathy of undetermined significance and multiple myeloma. Blood, 112, 3582-3586.
15. Kristinsson, S.Y., Pfeiffer, R.M., Björkholm, M., Goldin, L.R., Schulman, S., Blimark, C., Mellqvist, U.H., Wahlin, A., Turesson, I. & Landgren, O. (2010) Arterial and venous thrombosis in monoclonal gammopathy of undetermined significance and multiple myeloma: a population-based study. Blood, 115, 4991-4998.
16. Kyle, R.A. & Rajkumar, S.V. (2007) Monoclonal gammopathy of undetermined significance and smouldering multiple myeloma: emphasis on risk factors for progression. British Journal of Haematology, 139, 730-743.
17. Kyle, R.A., Therneau, T.M., Rajkumar, S.V., Larson, D.R., Plevak, M.F., Offord, J.R., Dispenzieri, A., Katzmann, J.A. & Melton, L.J. 3rd (2006) Prevalence of monoclonal gammopathy of undetermined significance. New England Journal of Medicine, 354, 1362-1369.
18. Muslimani, A.A., Spiro, T.P., Chaudhry, A.A., Taylor, H.C., Jaiyesimi, I. & Daw, H.A. (2009) Venous thromboembolism in patients with monoclonal gammopathy of undetermined significance. Clinical Advances in Hematology and Oncology, 7, 827-832.
19. Sallah, S., Husain, A., Wan, J., Vos, P. & Nguyen, N.P. (2004) The risk of venous thromboembolic disease in patients with monoclonal gammopathy of undetermined significance. Annals of Oncology, 15, 1490-1494.
20. Srkalovic, G., Cameron, M.G., Rybicki, L., Deitcher, S.R., Kattke-Marchant, K. & Hussein, M.A. (2004) Monoclonal gammopathy of undetermined significance and multiple myeloma are associated with an increased incidence of venothromboembolic disease. Cancer, 101, 558-566.
21. Zamagni, E., Brioli, A., Tacchetti, P., Zannetti, B., Pantani, L & Cavo, M. (2011) Multiple myeloma, venous thromboembolism, and treatment-related risk of thrombosis. Seminars in Thrombosis and Hemostasis, 37, 209-219.